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Abstract
The aggregation of amyloid β protein (Aβ) is a key step in the pathogenesis of Alzheimer’s disease (AD), and
therefore inhibitory substances for Aβ aggregation may have preventive and/or therapeutic potential for AD. Here we
report a novel microliter-scale high-throughput screening system for Aβ aggregation inhibitors based on fluorescence
microscopy-imaging technology with quantum-dot Nanoprobes. This screening system could be analyzed with a 5-µl
sample volume when a 1536-well plate was used, and the inhibitory activity could be estimated as half-maximal
effective concentrations (EC50). We attempted to comprehensively screen Aβ aggregation inhibitors from 52 spices
using this system to assess whether this novel screening system is actually useful for screening inhibitors. Screening
results indicate that approximately 90% of the ethanolic extracts from the spices showed inhibitory activity for Aβ
aggregation. Interestingly, spices belonging to the Lamiaceae, the mint family, showed significantly higher activity
than the average of tested spices. Furthermore, we tried to isolate the main inhibitory compound from Satureja
hortensis, summer savory, a member of the Lamiaceae, using this system, and revealed that the main active
compound was rosmarinic acid. These results demonstrate that this novel microliter-scale high-throughput screening
system could be applied to the actual screening of Aβ aggregation inhibitors. Since this system can analyze at a
microscopic scale, it is likely that further minimization of the system would easily be possible such as protein
microarray technology.
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Introduction
Many neurodegenerative disorders such as Alzheimer’s
disease (AD), Parkinson’s disease, prion disease, and
Huntington’s disease are associated with the aggregation and
deposition of misfolded proteins, the amyloids [1,2]. Since
aggregates containing oligomers and fibrils show toxicity
towards neuronal cells, amyloid aggregation inhibitors may be
key compounds in the regulation of these amyloid diseases. In
general, inhibitory activity against amyloid aggregation is
assessed by spectrophotometric assays using amyloid β
protein (Aβ)-binding dyes (e.g., thioflavin-T (ThT) and Congo
red [3,4,5]) or by direct observation of aggregates using
transmission electronic microscopy (TEM) [6,7,8] and/or atomic
force microscopy (AFM) [9,10]. However, dye-binding assays
that use ThT and Congo red to evaluate these inhibitory effects
could be prone to false positive effects because fluorescence
intensities of these dyes may be influenced by the inner filter
effects of contaminating compounds and/or the inhibitors
themselves [11]. Moreover, there is a possibility of competition
for binding between the dyes and inhibitors to amyloid fibrils.
These problems are significant when screening novel active
compounds. On the other hand, direct observation by TEM and
AFM with fixation and washing processes is unsuitable for
quantification and high-throughput analysis. Therefore, we
have been attempting to develop a novel high-throughput
screening system for amyloid aggregation inhibitors.
Recently we successfully developed real-time imaging and
quantification of Aβ42 aggregation using quantum-dot (QD)-
labeled Aβ40 (QDAβ) [12]. In that study, we showed that QDAβ,
which had a binding ratio (Aβ40/QD) of 6, was incorporated into
Aβ fibrils with a similar efficiency as unlabeled Aβ42 when
0.1-0.01% QDAβ was mixed with unlabeled Aβ42 [12]. The time
to reach the steady state was similar to that of intact Aβ42
measured from turbidity measurements [13]. Moreover, there
are only small amounts (0.1-0.01%) QDAβ relative to unlabeled
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Aβ42, suggesting that this imaging technology can monitor the
physiological aggregation of intact Aβ42. Since the amount of
aggregates decreased in the presence of anti-Aβ antibody, we
proposed that this imaging technology can be applied to the
microliter-scale screening of inhibitory substances for Aβ42
aggregation [12].
To attain a microliter-scale and high-throughput screening
system, in this study, we tried to optimize the observation
methods and to develop a simple quantification method from
fluorescence microscopic images. Furthermore, in order to
confirm whether this microliter-scale high-throughput screening
system can actually be used to screen Aβ aggregation
inhibitors, we attempted to screen inhibitory substances for Aβ
aggregation from 52 dried spices that include various plant
species that are readily commercially available.
Results
Methodology of the microliter-scale high-throughput
screening system for Aβ aggregation inhibitors
In this study, we used a 1536-well plate. When a 96-well
plate was used in a recent study [12], at least 40 µl of sample
volume was necessary to prevent the sample from drying. The
use of a 1536-well plate enabled the observation of aggregates
using a 5-µl sample volume without the drying side-effect. To
develop an image of Aβ aggregates, in this study, we used
Qdot655 and a customized the fluorescence filter block whose
excitation filter was adjusted from 425 nm to 470 nm to
attenuate the inner filter effect by substances in samples. For
example, maximum absorption of curcumin, which is a known
Aβ aggregation inhibitor, is 426 nm [11,14], so that
fluorescence intensity may be influenced if an excitation filter of
425 nm is used. Since Qdot655 has a higher extinction
coefficient than Qdot525, which we used recently [12], over a
wide range of excitation wavelengths, Qdot655 fluorescent light
could be sufficiently detected by a general CCD camera, even
when the excitation wavelength was 470 nm.
When 30 nM of QDAβ and 30 µM of Aβ42 were incubated in a
1536-well plate at 37 °C for 24 h, their aggregates were
visualized, as reported in our recent study [12] (Figure 1). First,
we examined the effect of EtOH on Aβ aggregation because
we used EtOH extracts of spices in the next screening step
(Figure 2). 40% EtOH immediately induced amorphous
aggregates, which are not fibrils, of QDAβ and Aβ42, and the
amorphous aggregates were eliminated by centrifugation at
10,000 xg for 2 min at 4 °C before incubation. Consequently, no
fluorescence was observed in the sample in the presence of
40% EtOH (Figure 2, 40%). When the sample was incubated
with 20% EtOH, it seemed that the aggregates were slightly
reduced (Figure 2, 20%). The data showed that the
aggregation was not affected by 10% EtOH (Figure 2, 10%), so
we performed all experiments in the presence of 5% EtOH in
this study.
Next, we explored a way to quantify the amount of
aggregates from the fluorescence microscopy images. We had
already reported that the volume of Aβ aggregates can be
estimated from 3D-images by confocal fluorescence
microscopy [12]. However, the time taken for 3D-image
Figure 1.  Imaging of Aβ42 aggregation using a QDAβ
nanoprobe.  (A) QDAβ was prepared by crosslinking CysAβ40
and amino (PEG) Qdot655 according to our recent study [12]
(left). QDAβ coaggregated with unlabeled Aβ42, and the Aβ42
fibrils that formed could be visualized under fluorescence
microscopy (right). (B) 30 nM QDAβ and 30 µM unlabeled Aβ42
was incubated at 37 °C for 24 h in a 1536-well plate, and was
observed using an inverted fluorescence microscope using a
4x objective. Left and right panels show before and after
incubation, respectively. (C) Magnified image of the aggregates
observed using a 10× objective.
doi: 10.1371/journal.pone.0072992.g001
Figure 2.  Effect of EtOH on Aβ42 aggregation.  30 nM QDAβ
and 30 µM Aβ42 were mixed in 1xPBS, 3% DMSO containing 0,
2.5, 5, 10, 20, or 40% EtOH, each sample was incubated at 37
°C for 24 h in a 1536-well plate. The wells were observed using
an inverted fluorescence microscope using a 4x objective. The
images show 200 × 200 pixels in the center of each well.
doi: 10.1371/journal.pone.0072992.g002
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acquisition is longer than that for 2D-image acquisition, and
data size of the 3D-image is also larger than that of the 2D-
image because one 3D-image reconstruction requires several
dozen 2D-images. Therefore, we considered a simple
quantification method from one 2D-image. Before incubation,
QDAβ molecules were dispersed in a sample solution, so that
the fluorescence micrograph showed a uniform red color
(Figure 3A; left panel). After incubation, Aβ aggregates that
were visualized by QDAβ were observed on the well bottom
(Figure 3A; right panel). This aggregation resulted
Figure 3.  Correlation between Aβ aggregation and
variations of fluorescence intensity.  (A) Magnified images
of center region (100 × 100 pixel) in fluorescence micrographs
of QDAβ- Aβ42 coaggregates before (left) and after (right)
incubation (Figure 1B). (B) Schematic illustrations of the
distribution of QDAβ (red) and Aβ42 (gray) molecules before
(left) and after (right) incubation of samples. QDAβ molecules
are diffused in the sample solution before incubation (left), and
QDAβ molecules are inserted in Aβ42 fibrils after incubation
(right). (C) The histograms of fluorescence intensities of 10,000
pixels (100 × 100 pixel) before (left) and after (right) incubation
of samples.
doi: 10.1371/journal.pone.0072992.g003
inhomogeneous distribution of fluorescence intensity in
micrographs (Figure 3B). The histogram of fluorescence
intensities of 10,000 pixels (100 × 100 pixels) prior to sample
incubation was narrow but that after sample incubation was
broad, and the standard deviation (SD) of post-incubation
samples was larger than that of pre-incubation samples (Figure
3C), suggesting that SD values correlated with the amount of
Aβ aggregates. That is, as Aβ aggregation progressed, the
variability of fluorescence intensities of each pixel increased,
and standard deviation (SD) values also increased.
To confirm the correlation between the amount of Aβ
aggregates and SD values, we attempted a concentration-
dependent assay (Figure 4). 30 nM QDAβ and various
concentrations of Aβ42 were incubated in a 1536-well plate and
the images (Figure 4A) were analyzed using ImageJ software
(NIH). When the Aβ42 concentration was low (10–25 µM),
diffused QDAβ molecules were observed in the intervening
space between Aβ aggregates, so that the intervening spaces
remained red due to QDAβ (Fig. 4A). When Aβ42 concentration
was around 30 µM, almost all QDAβ molecules were inserted
into Aβ42 fibrils, so that the intervening spaces were darker than
that of the low Aβ42 concentrations (Fig. 4A). When Aβ42
concentration was high (40–50 nM), accumulated Aβ
aggregates at the well bottom were thick, so that out-of-focus
aggregates were imaged in the fluorescence micrographs,
causing a blurred image (Fig. 4A). The thickness of Aβ
aggregates on the well bottom was about 50 µm when 100 µM
Aβ42 was incubated in a 96-well plate [12]. The depth of sample
solutions in the 96-well plate and in the 1536-well plate is the
same (2 mm), suggesting that the thickness of aggregates
might be about 15 µm in the presence of 30 µM Aβ42. Since the
depth of focus of the microscopic system used in this study
was approximately 14 µm it is likely that the gradual decrease
of SD values (Figure 4B) over 30 µM of Aβ42 concentration was
caused by an increase of out-of-focus aggregates. Linear
regression analysis showed that the SD values from the
fluorescence micrographs increased in a concentration-
dependent manner at less than 30 µM of Aβ42 (R2 = 0.93)
(Figure 4B). In this study, therefore, we screened using 30 µM
Aβ42 in the following steps. Furthermore, we confirmed whether
time-dependent SD values increased as Aβ aggregation
progressed. The micrographs showed time-dependent
aggregation (Figure 5A), and the SD values also increased in a
time-dependent manner (Figure 5B). The time-dependent
graph (Figure 5B) showed a typical kinetic curve for amyloid
aggregation which consisted of time lag, growth, and steady
state phases, similar to recent 3D volume data by confocal
microscopy [12]. Although we have no conclusive evidence
whether SD values increase in direct proportion to the amount
of Aβ42 aggregates, the concentration- (Figure 4B) and time-
dependent (Figure 5B) SD data suggests that the SD values
could be used as an approximate indicator of Aβ aggregates.
Since the time-dependent data revealed that the aggregation
reached a plateau around 24 h (Figure 5B), incubation time
was fixed at 24 h in the following screening steps.
On the basis of the above results, we set up the microliter-
scale high-throughput screening system as mentioned in the
Experimental section and Figure 6. Simply put, various
A Screening System for Aβ Aggregation Inhibitor
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concentrations of candidate inhibitors were incubated with 30
nM QDAβ and 30 µM Aβ42 in a 1536-well plate (Figures 6 and
7A) at 37 °C for 24 h, and SD values of fluorescence intensity in
each micrograph were analyzed by ImageJ software. The half-
maximal effective concentration (EC50) values of inhibitors
could be estimated from the inhibition curves (Figure 7B).
Figure 7D shows the actual inhibition curves of well-known Aβ
aggregation inhibitors that were determined from the SD values
of fluorescence micrograph data (Figure 7C). The EC50 could
be estimated from the inhibition curves using an EC50 shift by
the Prism global fitting program (GraphPad software).
Comprehensive screening of Aβ aggregation inhibitors
from 52 spices
Since we confirmed that the microliter-scale high-throughput
screening system can be applied to estimate the EC50 of Aβ
aggregation inhibitors, we then tried to actually screen the
EtOH extracts of 52 dried spices belonging to 19 plant families
(Figure 8). The results revealed that many spices (about 90%)
had inhibitory activity for Aβ aggregation when the extracts
were added at a high concentration (~10 mg). On the other
hand, there are five spices that did not show inhibitory activity
(Figure 8), demonstrating that this high degree of inhibitory
success was not caused by methodological problems of this
screening system. That is, it is likely that the “not effective”
Figure 4.  Concentration-dependent Aβ aggregation.  (A) Various concentrations of Aβ42 and 30 nM QDAβ were incubated in a
1536-well plate at 37 °C for 24 h. Each well was observed using an inverted fluorescence microscope using a 4x objective. (B)
Variations of fluorescence intensities of 10,000 pixels (100 × 100 pixel) in the center region of micrographs were estimated as SD
values, the mean values were plotted against the concentrations of added Aβ42. A linear equation and R2 in B were determined
using the data of less than 30 µM of Aβ concentrations. Error bars represent ±SDs of the mean values of fluorescence intensities
(n=3 separate experiments).
doi: 10.1371/journal.pone.0072992.g004
Figure 5.  Time-dependent Aβ aggregation.  (A) 30 nM QDAβ and 30 µM Aβ42 were incubated in a 1536-well plate at 37 °C, and
observed over time by an inverted fluorescence microscope using a 4x objective. All images show the same field of a well. (B)
Variations of fluorescence intensities of 10,000 pixels (100 × 100 pixel) in the center region of micrographs were estimated as SD
values, the mean values were plotted against incubation time periods. Error bars represent ±SDs of the mean values of
fluorescence intensities (n=3 separate experiments).
doi: 10.1371/journal.pone.0072992.g005
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spices were comparable to negative controls of this screening
system. The spices belonging to the Lamiaceae and Myrtaceae
families showed significantly higher inhibitory activity against
Aβ aggregation than other family members. Especially, thyme
(Thymus vulgaris) (EC50 = 0.035 ± 0.015 mg/ml), summer
savory (Satureja hortensis) (EC50 = 0.049 ± 0.056 mg/ml), and
spearmint (Mentha spicata) (EC50 = 0.018 ± 0.005 mg/ml), all
belonging to the Lamiaceae (mint) family, affected Aβ
aggregation at 0.01 mg/ml (Figure 8, gray cells on 0.01 mg/ml
line). Although green pepper (Piper nigrum) also affected SD
values at 0.01 mg/ml it is likely that the result was an error
because the effect was not observed at 0.1 mg/ml of extract
Figure 6.  A flow diagram of the microliter-scale high-
throughput screening system.  Various concentrations of
known inhibitors or spice extracts were incubated with 30 µM
Aβ42 and 30 nM QDAβ in a 1536-well plate, and incubated to
induce the aggregation of Aβ42. Aggregates of Aβ42 and QDAβ
were imaged by fluorescence microscopy, and EC50 of the
inhibitory activities were estimated from the fluorescence
micrograph data A more detailed method is mentioned in the
experimental section.
doi: 10.1371/journal.pone.0072992.g006
Figure 7.  Estimation of EC50 by the microliter-scale high-
throughput screening system.  (A) A schematic illustration of
a microliter-scale high-throughput screening system for three
samples. (B) The concept of estimation of EC50 values from
inhibition curves that are a plotted percentage of SD versus
concentrations of inhibitors. The EC50 of sample A is higher
than that of sample C, and sample B did not inhibit Aβ
aggregation. (C and D) Estimations of EC50 of well-known
inhibitors, curcumin (Cur), rosmarinic acid (RA), tannic acid
(TA), and myricetin (Myr). 30 nM QDAβ and 30 µM Aβ42 was
incubated with various concentrations of the four inhibitors at
37 °C for 24 h (C). The SD values from the fluorescence
images plotted against several concentrations of inhibitors (D).
Error bars represent ±SDs of the mean values from
fluorescence intensities (n=3 separate experiments). EC50
values of Cur, RA, TA, and Myr were 31 ± 16, 11 ± 2, 1.8 ± 1.5,
and 1.0 ± 0.3 µM, respectively.
doi: 10.1371/journal.pone.0072992.g007
A Screening System for Aβ Aggregation Inhibitor
PLOS ONE | www.plosone.org 5 August 2013 | Volume 8 | Issue 8 | e72992
concentration. All spices that did not show inhibitory activity
(Figure 8, poppy seed (Papaver somniferum), basil seed
(Ocimum basilicum), red pepper (Capsium annuum), coriander
(Coriandrum sativum), and cumin (Cuminum cyminum)) were
spices originating from seeds while only red pepper contained
fruit.
We then tried to isolate the main active substance from
summer savory, which was one of the spices that showed the
highest inhibitory activity, under the guidance of the inhibitory
effect (EC50) against Aβ aggregation determined by the
microliter-scale high-throughput screening system (Figure 9).
The ethanolic extract (32 g) of dried summer savory (500 g)
was successively partitioned between CHCl3, AcOEt, n-BuOH
and H2O (Figure 9A). The AcOEt layer, the best active fraction,
was applied to silica gel column chromatography, reverse
phase column chromatography, gel filtration, and reverse
phase HPLC to give a single compound (131 mg) (Figure 9A),
which had ESI-MS, NMR, and IR spectra identical to rosmarinic
acid (RA). The inhibitory activities of the isolated RA and
standard RA analyzed by the microliter-scale high-throughput
screening system (Figure 9B, top) and the ThT assay (Figure
9B, bottom) were similar, supporting the conclusion that the
isolated substance was RA.
Discussion
In this study, we successfully developed a novel microliter-
scale high-throughput screening system with QD for Aβ
aggregation inhibitors (Figure 6). The comprehensive
screening of Aβ aggregation inhibitors for 52 spices using the
screening system revealed that almost all spices had inhibitory
activity for Aβ aggregation (Figure 8). Masuda et al. [15]
reported that many polyphenols inhibit the aggregation of Aβ
and α-synuclein, which is another amyloid. Polyphenols are
natural substances present in many plants that are consistent
with our result showing that almost all of the 52 spices tested
had inhibitory activity. Furthermore, we demonstrated that the
Lamiaceae family, except for basil seed, showed higher
inhibitory activity against Aβ aggregation than all other plant
families (Figure 8), and that RA was the main active substance
of summer savory (Figure 9). These results suggest that this
system could be applied to the actual screening of Aβ
aggregation inhibitors.
RA was previously reported to inhibit Aβ aggregation in vitro
[16] and Aβ deposition of RA-treated AD model transgenic
mice decreased significantly in the brain [17]. Moreover, it was
reported that RA prevented Aβ oligomerization and synaptic
dysfunction by site-specific binding [18]. Interestingly, Salvia
officinalis (sage) and Melissa officinalis (lemon balm), also
belonging to the Lamiaceae family, had already been reported
to have memory-improving properties in old European
reference books hundreds of years ago [19]. It is possible that
the effect involves the inhibitory activity of Aβ aggregation of
RA, which is found in members of the Lamiaceae family [20].
We also found that some fractions, which were separate
fractions in the isolation process from summer savory (Figure
9), showed higher inhibitory activity than RA, but that the
content was smaller than RA, thus, they were not major active
Figure 8.  Estimation of EC50 values of EtOH extracts from
52 spices using the microliter-scale high-throughput
screening system.  Screening was applied to examine the
EtOH extracts of dried spices. The ‘black’, ‘gray’, and ‘white’
cells indicate ‘not inhibited (SD ≥ 80%)’, ‘partially inhibited
(80% > SD > 20%)’, and ‘completely inhibited (20% ≥ SD)’
wells, respectively. The percentage of SD was defined as SD
values before and after incubation of control samples (0% and
100%, respectively). EC50 values were estimated from dose-
dependent inhibition curves (n=3 separate experiments).
Spices were aligned using the Angiosperm Phylogeny Group
classification (APG III) [25].
doi: 10.1371/journal.pone.0072992.g008
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fractions. Since this screening system can evaluate a small
amount of sample, we are now trying to isolate the highly active
compounds from the fractions (data to be published soon).
The EC50 values that were determined by the microliter-scale
high-throughput screening system (Figures 7 and 9) showed a
tendency to be higher than the values that were determined by
ThT fluorescent intensities [15,16,21]. As mentioned above, it
has been reported that a dye-binding assay using ThT has the
potential to show false positive effects such as inner filter
effects [11]. In contrast, since this screening system adopts a
longer excitation spectrum and quantification from variability
data of fluorescence intensity, it is likely that the inner filter
effects are smaller than those of the ThT assay.
Recently, potent amyloidogenicity and pathogenicity of Aβ43
was reported [22]. The microliter-scale high-throughput
screening system can be applied easily by changing unlabeled
Aβ42 peptide to Aβ43 peptide. Furthermore, this system could be
applied to screening inhibitors for the aggregation of other
amyloid peptides such as α-cynuclein, huntingtin, and prion. In
addition, it is likely that this principle can be used to screen
Figure 9.  Isolation and identification of active compound
from EtOH extract of summer savory.  (A) A flow diagram of
isolation steps. (B) Inhibition curves of isolated RA from
summer savory (squares) and standard RA (triangles) were
determined by the microliter-scale high-throughput screening
(MHS) system (B, top) and the ThT assay (B, bottom). Vertical
axes of the MHS system and the ThT assay are the percentage
of average SD values and the percentage of average
fluorescence intensity (FI) values, respectively. The EC50
values of isolated RA and standard RA determined by the MHS
system were 9.6 ± 0.1 and 11 ± 2 µM, respectively. In contrast
to that, the EC50 values of isolated RA and standard RA
determined by ThT assay were 8.6 ± 0.8 and 6.3 ± 1.5 µM,
respectively. Error bars represent ±SDs (n=3 separate
experiments).
doi: 10.1371/journal.pone.0072992.g009
inhibitors or promoters for polymerization of normal filament-
forming protein such as actin and microtubules.
The toxicity of soluble oligomers is a trigger for
neurodegenerative diseases [23,24], indicating that Aβ
oligomerization inhibitors are also important for preventive
and/or therapeutic agent. The growth of aggregates occurred
after the nucleation step, i.e., the oligomerization step,
suggesting that oligomerization inhibitors also affect the
amount of Aβ aggregates in the same incubation period. In
fact, it was recently demonstrated that RA and Myr blocked Aβ
oligomerization [18]. Therefore, it is reasonable to assume that
oligomerization inhibitors can be screened as a second
screening after the first comprehensive screening of Aβ
aggregation inhibitors using this microliter-scale high-
throughput screening system. We have already proposed a
quantification method for oligomerization using QDAβ in a
recent report [12]. It is likely that the combination of these
methods would be useful to screen inhibitory substances for
each aggregation process.
Although this system could quantify Aβ aggregation with only
a 5-µl sample volume when a 1536-well plate was used, further
minimization is possible such as protein microarray technology
because the microscopic sample size is sufficient for data
analysis in this system. This minimization would allow for more
high-throughput screening. In addition, it is also one of the
biggest advantages that this system does not need any
handling processes, such as sample transfer by pipetting, after
aggregation. Amyloid aggregates are hydrophobic and stick to
plastic surfaces, and therefore are easy to adhere to, including
to micropipette tips, microtubes, and multi-well plates. This can
be a cause of a serious experimental error in the quantification
of aggregates.
Although many compounds have shown inhibitory activity
against Aβ aggregation [15], the mechanism of inhibition
remains unknown. Since this microliter-scale high-throughput
screening system can be applied to comprehensive screening,
the isolation of Aβ aggregation inhibitors from natural sources
and chemical libraries may be accelerated from now on. It is
expected that a quantitative structure-activity relationship
study, which would use many types of inhibitors that can be
identified by this screening system, would demonstrate an
inhibition mechanism. Such information would be helpful in the
molecular design of inhibitors in drug discovery. Our hope is
that this novel technology may be a powerful tool for the
analysis of protein aggregation/assembly.
Experimental Section
Materials
Human amyloid peptides of Aβ42 (4349-v, Peptide Institute)
and Cys-conjugated Aβ40 (CysAβ) (23519, Anaspec) were
dissolved at a concentration of 1 mg/ml in 1,1,1,3,3,3-
hexafluoro-2-propanol (083-04231, Wako Pure Chemical
Industries), incubated at room temperature for 1 h, and
sonicated for 10 min. The aliquots were dried down in
microcentrifuge tubes and the dried films were stored at -20 °C.
N-(6-maleimidocaproyloxy) sulfosuccinimide ester (Sulfo-
EMCS) (22307, Pierce) was stored at 4 °C and dissolved in 8.1
A Screening System for Aβ Aggregation Inhibitor
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mM Na2HPO4, 1.5 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH
7.4 (PBS) immediately before use. Amine-derivatized
polyethylene glycol (PEG)-conjugated Qdot655 (QD-PEG-NH2)
(Q21521MP, Life Technologies) was stored at 4 °C. Known
standard inhibitors, curcumin (038-04921), tannic acid
(201-06332), myricetin (137-16791), and rosmarinic acid
(182-02691), were purchased from Wako Pure Chemical
Industries. All dried spices were purchased from S&B Foods
Inc. All other chemicals were of reagent grade.
Preparation of QDAβ
QDAβ was prepared according to our recent report [12] and
a book (K. Tokuraku & T. Ikezu, Imaging of amyloid-β
aggregation using a novel quantum dot nanoprobe and its
advanced applications, Bionanoimaging-Insights into protein
misfolding & aggregation, edited by Yuri Lyubchenko &
Vladimir Uversky, Elsevier, in press). 10 µM QD-PEG-NH2 was
first reacted with 1 mM sulfo-EMCS in PBS for 1 h at 20 °C.
After quenching and elimination of unreacted sulfo-EMSC, the
QD-PEG-NH2-bound sulfo-EMCS was reacted with 100 µM
CysAβ in PBS containing 5 mM EDTA for 1 h at 20 °C. The
labeling ratio of Aβ to QD can be controlled by the initial
concentration of the added CysAβ [12]. In this condition, the
labeling ratio (Aβ/QD) was estimated as being approximately 6
[12]. The concentrations of QDAβ were determined at an
absorbance of 504 nm according to instruction manual of Life
Technologies.
Microliter-scale high-throughput screening system
Dried Aβ42 films were completely dissolved in 1 mM DMSO
by pipetting for at least 15 min with the tip of a micropipette
pressed on the bottom of a microtube. QDAβ and the dissolved
Aβ42 were mixed in 1x PBS at final concentrations of 60 nM and
60 µM, respectively. 3 µl of the mixture of QDAβ and Aβ42 and
3 µl of various concentrations of inhibitors or spice extracts,
which were diluted in 1x PBS containing 10% EtOH, were
mixed (final condition was various concentrations of inhibitors
or spice extracts, 30 nM QDAβ, 30 µM Aβ42, 1x PBS, 5% EtOH,
3% DMSO), and centrifuged at 10,000 xg for 2 min at 4 °C to
eliminate any insoluble dusts. 5 µl of the supernatants were
transferred into each well of a 1536-well plate (782096,
Greiner), and were tightly sealed with vinyl tapes to prevent the
drying of sample solutions in wells. The 1536-well plate with
sample solutions was centrifuged by a multi-well plate
centrifuge (PlateSpin II, Kubota) at 1,530 xg for 5 min at room
temperature to flatten the surface of sample solutions, and
incubated at 37 °C for 24 h in an air incubator (SIB-35,
Sansyo). The 1536-well plate was observed by an inverted
fluorescence microscope (Diaphot 300, Nikon) equipped with a
color CCD camera (DP72, Olympus). QDAβ was imaged using
a customized Qdot655 filter set (XF305-1, Omega optical;
excitation 425DF45, dichroic 475DCLP, emission 655DF20) in
such a way that the excitation filter was replaced by another
filter (Ex 450-490 nm, Nikon) in order to reduce the interfering
QD excitation by components in spice extracts and by the
inhibitory compound itself.
Estimation of EC50 from fluorescence microscopy
images
To estimate the half-maximal effective concentration (EC50)
that would inhibit Aβ aggregation, we used fluorescence
micrograph data that was taken using a 4x objective lens with a
customized Qdot655 filter set. Fluorescence intensities of
10,000 pixels (100 × 100 pixels: 280 × 280 µm) in the central
region of each well and the SD values were measured by
ImageJ software (NIH). The means and ±SDs of the mean
values were calculated from three independent experiments.
We defined EC50 as the inhibitor concentration when the SD
value showed half of the maximum (after incubation) and
minimum (before incubation) SDs of control sample without
inhibitor. In particular, the inhibition curves (e.g. Figure 1G)
were analyzed with Prism (GraphPad software) using an EC50
shift by global fitting (Asymmetric sigmoidal, 5 parameter
logistic).
Estimation of EC50 from ThT fluorescence intensities
EC50 for Aβ aggregation by ThT fluorescence was
determined according to the method of Levine [4] modified in
our laboratory. ThT (202-01002, Wako Pure Chemical
Industries) was dissolved in water at 100 µM for 1 day at room
temperature under constant stirring and shielded from light.
The 100 µM ThT solution was diluted immediately before use in
50 mM glycine/KOH buffer (pH 8.5) to a final concentration of 5
µM. 30 µM Aβ42 and various concentrations of inhibitors were
incubated in 1x PBS containing 5% EtOH and 3% DMSO for 24
h at 37°C. 10 µl of the incubated samples were added to 190 µl
of 5 µM ThT solution, and the fluorescence intensity was
measured at 490 nm after excitation at 455 nm in micro
fluorimeter cells (FM20B, GL Science) using a fluorescence
spectrophotometer (F-4500, Hitachi). EC50 was estimated from
an inhibition curve using the EC50 shift by Prism global fitting
software.
Preparation of EtOH extracts from 52 dried spices
One g of each dried spice was extracted with 5 ml of EtOH at
room temperature for 7 days. The EtOH solution was filtered
and concentrated in vacuo.
Isolation of active compound from summer savory
Dried summer savory (500 g) was extracted with 2.5 l of
EtOH at room temperature for 7 days. The EtOH extract was
filtered and concentrated in vacuo to yield a residue (32 g) that
was partitioned between CHCl3, AcOEt, n-BuOH and H2O.
Column chromatography of the concentrated AcOEt layer (1.41
g) on silica gel (100 g) (n-hexane-AcOEt (6:4, 5:5, 4:6, 3:7, 2: 8
v/v), AcOEt, AcOEt-MeOH (9:1, 7: 3 v/v) and MeOH) yielded
10 fractions (fractions A to J). Fraction E (0.44 g), which was
eluted with n-hexane-AcOEt (3: 7 v/v), was subjected to
reverse phase column chromatography (Cosmosil 75C18-OPN,
Nacalai Tesque) using CH3CN–H2O as the eluting solvent, gel
filtration (Sephadex LH-20 Lab Paks, GE Healthcare) using
MeOH as the eluting solvent and HPLC (TOSOH CCPE HPLC
Pump, Tosoh Corp.) that was equipped with a reverse phase
column (Cosmosil 20x250 mm 5C18-Ms-II, Nacalai Tesque).
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The eluent was monitored at 220 nm using a Tosoh UV-8011
Tunable Absorbance Detector (Tosoh Corp.). Chromatographs
were recorded using a Chromato-Pro PC integrator (Run Time
Co. Ltd.) to give RA (131 mg) as an amorphous solid: [α]D26
+161.9° (c 0.42, MeOH) IR (solid) νmax: 3330 (OH stretch), 1685
(C=O stretch) cm-1. 1H-NMR (500 MHz, CD3OD) δ 7.55 (d, 1H,
J = 16.0 Hz, H-7), 7.03 (d, 1H, J = 1.8 Hz, H-2), 6.94 (dd, 1H, J
= 1.7, 8.0 Hz, H-6), 6.77 (d, 1H, J = 8.0 Hz, H-5), 6.74 (d, 1H, J
= 1.8 Hz, H-2’), 6.68 (d, 1H, J = 8.0 Hz, H-5’), 6.60 (dd, 1H, J =
1.7, 8.0 Hz, H-6’), 6.26 (d, 1H, J = 16.0 Hz, H-8), 5.17 (dd, 1H,
J = 4.0, 8.5 Hz, H-8’), 3.09 (dd, 1H, J = 4.0, 14.3 Hz, H-7’a),
3.00 (dd, 1H, J = 8.5, 14.3 Hz, H-7’b). 13C-NMR (125 MHz,
CD3OD) δ: 173.67 (s, C-9’), 168.46 (s, C-9), 149.60 (s, C-4),
147.68 (d, C-7), 146.66 (s, C-3), 146.00 (s, C-3’), 145.12 (s,
C-4’), 129.22 (s, C-1’), 127.55 (s, C-1), 123.15 (d, C-6), 121.79
(d, C-6’), 117.51 (d, C-2’), 116.43 (d, C-5), 116.23 (d, C-5’),
115.15 (d, C-2), 114.29 (d, C-8), 74.66 (d, C-8’), 37.81 (t, C-7’).
FAB-MS (positive, NBA) m/z: 383 (M++Na), 361 (M++H), 180
(caffeic acid), 163 (100%, caffeic acid-H2O). High-resolution
FAB-MS calcd for C18H17O8: 361.0923. Found: 361.0920.
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